Stocks / GSK (LSE: GSK) / LSE:GSK (GSK)About GSKGlaxoSmithKline is one of the worlds leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000. Summary Profile Price History Financials Peer Comparison Share Info Performance Dividends Events GSK (LSE: GSK) Latest News Investing Articles “The last FTSE 100 stock I’d sell in a recession is…” 10 April, 2024 | The Motley Fool Staff It's well worth considering some recession-resiliant stocks as part of a diversifed portfolio. Here, our free-site writers offer up their… Read more » Investing Articles 2 FTSE stocks I’d be willing to put 100% of my money into for passive income! 9 April, 2024 | Sumayya Mansoor If I were only able to buy a limited number of stocks to generate a passive income stream, I’d definitely… Read more » Investing Articles If I was retiring tomorrow, I’d buy these 3 unmissable FTSE income stocks 7 April, 2024 | Harvey Jones Harvey Jones is on the prowl for top FTSE 100 dividend income stocks. He thinks these three are unmissable buys,… Read more » Investing Articles 2 FTSE 100 shares I’d buy as the index hits 8,000 points! 2 April, 2024 | Royston Wild I think these FTSE 100 shares could be a steal at current prices. Here's why I think they could continue… Read more » Investing Articles Best British stocks to consider buying in April 1 April, 2024 | The Motley Fool Staff We asked our writers to share their ‘best of British’ stocks to buy this month, including one 'Fire' and one… Read more » Investing Articles I’d like to buy these 3 bargains for my Stocks and Shares ISA before the FTSE climbs higher 22 March, 2024 | Harvey Jones As the FTSE 100 surges and a host of shares look like ending the week a lot higher, Harvey Jones… Read more » Investing Articles I’d consider buying this FTSE 100 dividend stock before it’s revalued for growth 20 March, 2024 | Kevin Godbold This may be a rare opportunity for me to buy a decent dividend stock with the possibility of a valuation… Read more » Investing Articles 2 last-minute FTSE 100 shares I’m considering buying before the ISA deadline 18 March, 2024 | Royston Wild These FTSE 100 shares could be too cheap to miss, according to our writer Royston Wild. Here's why they're on… Read more » Investing Articles Is GSK’s share price set to soar on a new cancer drug? 13 March, 2024 | Simon Watkins New drugs lines may boost GSK’s share price even further, but even without these, the business looks very undervalued against… Read more » Investing Articles I’m itching to buy these 3 hidden FTSE gems in a Stocks and Shares ISA 25 February, 2024 | Harvey Jones Harvey Jones is keen to add these three FTSE 100 companies to his Stocks and Shares ISA before April. Only… Read more » Investing Articles Despite being around an 18-month high, GSK’s share price looks cheap to me 20 February, 2024 | Simon Watkins GSK’s share price has risen over the past 18 months, but it still looks undervalued against its peers, and new… Read more » Investing Articles Just released: our 3 top income-focused stocks to buy before March [PREMIUM PICKS] 20 February, 2024 | Mark Rogers Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due… Read more » ❮1…45678…❯
Investing Articles “The last FTSE 100 stock I’d sell in a recession is…” 10 April, 2024 | The Motley Fool Staff It's well worth considering some recession-resiliant stocks as part of a diversifed portfolio. Here, our free-site writers offer up their… Read more »
Investing Articles 2 FTSE stocks I’d be willing to put 100% of my money into for passive income! 9 April, 2024 | Sumayya Mansoor If I were only able to buy a limited number of stocks to generate a passive income stream, I’d definitely… Read more »
Investing Articles If I was retiring tomorrow, I’d buy these 3 unmissable FTSE income stocks 7 April, 2024 | Harvey Jones Harvey Jones is on the prowl for top FTSE 100 dividend income stocks. He thinks these three are unmissable buys,… Read more »
Investing Articles 2 FTSE 100 shares I’d buy as the index hits 8,000 points! 2 April, 2024 | Royston Wild I think these FTSE 100 shares could be a steal at current prices. Here's why I think they could continue… Read more »
Investing Articles Best British stocks to consider buying in April 1 April, 2024 | The Motley Fool Staff We asked our writers to share their ‘best of British’ stocks to buy this month, including one 'Fire' and one… Read more »
Investing Articles I’d like to buy these 3 bargains for my Stocks and Shares ISA before the FTSE climbs higher 22 March, 2024 | Harvey Jones As the FTSE 100 surges and a host of shares look like ending the week a lot higher, Harvey Jones… Read more »
Investing Articles I’d consider buying this FTSE 100 dividend stock before it’s revalued for growth 20 March, 2024 | Kevin Godbold This may be a rare opportunity for me to buy a decent dividend stock with the possibility of a valuation… Read more »
Investing Articles 2 last-minute FTSE 100 shares I’m considering buying before the ISA deadline 18 March, 2024 | Royston Wild These FTSE 100 shares could be too cheap to miss, according to our writer Royston Wild. Here's why they're on… Read more »
Investing Articles Is GSK’s share price set to soar on a new cancer drug? 13 March, 2024 | Simon Watkins New drugs lines may boost GSK’s share price even further, but even without these, the business looks very undervalued against… Read more »
Investing Articles I’m itching to buy these 3 hidden FTSE gems in a Stocks and Shares ISA 25 February, 2024 | Harvey Jones Harvey Jones is keen to add these three FTSE 100 companies to his Stocks and Shares ISA before April. Only… Read more »
Investing Articles Despite being around an 18-month high, GSK’s share price looks cheap to me 20 February, 2024 | Simon Watkins GSK’s share price has risen over the past 18 months, but it still looks undervalued against its peers, and new… Read more »
Investing Articles Just released: our 3 top income-focused stocks to buy before March [PREMIUM PICKS] 20 February, 2024 | Mark Rogers Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due… Read more »